Who owns PDL BioPharma?

Key details on PDL BioPharma (Ticker: PDLI)

Who owns PDL BioPharma?

Is PDLI a good stock to own? Find out who bought PDL BioPharma, who sold PDL BioPharma (PDLI) stock, and who holds a large position in PDL BioPharma.

Fund Name Number of Shares Share Valuation As Of
Renaissance Technologies 12.90M $124.84M June 30, 2014
BlackRock Fund Advisors 11.54M $86.23M Sept. 30, 2014
Vanguard 10.17M $98.44M June 30, 2014
Schroder Investment Management 8.73M $84.50M June 30, 2014
Baupost 8.00M $49.60M Dec. 31, 2011
Acadian Asset Management 6.59M $49.25M Sept. 30, 2014
FMR 6.37M $49.20M June 30, 2013
Advisors Asset Management 4.73M $45.76M June 30, 2014
BlackRock Institutional Trust Company, N.A. 4.56M $34.10M Sept. 30, 2014
Wells Fargo & Company 4.10M $39.68M June 30, 2014
STATE STREET CORPORATION 3.59M $34.77M June 30, 2014
Gotham Asset Management 3.34M $28.22M Dec. 31, 2013
Inves 3.25M $27.00M March 31, 2014
AQR Capital Management 2.98M $22.97M June 30, 2013
MSDC Management 2.86M $18.94M June 30, 2012
OppenheimerFunds 2.82M $18.71M June 30, 2012
Two Sigma Advisers 2.80M $21.52M Sept. 30, 2012
DIMENSIONAL FUND ADVISORS 2.71M $26.27M June 30, 2014
NORTHERN TRUST 2.64M $21.77M March 31, 2014
Bank of America Corporation 2.64M $21.91M March 31, 2014
NUMERIC INVESTORS 2.42M $20.40M Dec. 31, 2013
Royal Bank of Canada 2.28M $22.11M June 30, 2014
Hussman Econometrics Advisors 2.22M $17.68M Sept. 30, 2013
Two Sigma Investments 2.17M $15.86M March 31, 2013
Frank Russell Company 2.14M $20.75M June 30, 2014
ARONSON JOHNSON ORTIZ 2.09M $16.13M June 30, 2013
LSV Asset Management 2.07M $16.47M Sept. 30, 2013

Who sold PDL BioPharma?

Fund Name Date Sold Number of Shares Sold Share Valuation
First Eagle Investment Management Dec. 31, 2010 3.55M $22.12M
Paulson & Co March 31, 2008 5.40M $57.16M